维普中文期刊产品整合服务
60篇 您的检索式:作者名="Kajdasz"
    题名 作者 年代 出处 被引量
1Is treatment associated hypomania rare with duloxetine :Secondary analysis of controlled tri- als in non -- bipolar depression显示文摘Dunner D L DSouza D N Kajdasz D K 2005J Affect Disord2005,87,:1
2A randomized, double-blind, plaeebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder 显示文摘KHAN A CUTLER AJ KAJDASZ DK 2011J Clin Psyehiatry2011,72,4:1
3Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy显示文摘Backskai B J Kajdasz ST Christie RH 2001Nat Med2001,7,3:1
4Is treatment - associated hypomania rare with duloxetine:secondary analysis of controlled trails in non-bipolar depression 显示文摘DUNNER DL DSOUZA DN KAJDASZ DK 2005Affect Disord2005,87,1:1
5A 1-year, open- lable study assessing the safety and tolerability of vilazodone in pa- tients with major depressive disorder 显示文摘Robinson DS Kajdasz DK Gallipoli S 2011Clin Psychopharmacol2011,31,5:1
6Safety and tolerability of du- loxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo - controlled clinical trials 显示文摘Hudson JI Wohlreich MM Kajdasz DK 2005Human Psychophar-macology : Clinical and Experimental2005,20,5:1
7Safety and tolerability of patients with fibromyalgia : pooled analysis of data from five clinical trias 显示文摘Choy EH Mease PJ Kajdasz DK 2009Clin Rheumatol2009,28,:1
8A randomized, doub- leblind, placebo-controlled, 8-week study of vilazodone, a sero- tonergic agent for the treatment of major depressive disorder 显示文摘Khan A Cutler AJ Kajdasz DK 2011J ClinPsychiatry2011,72,4:1
9度洛西汀在安慰剂对照试验中的剂量应答关系显示文摘Bech P Kajdasz DK Porsdal V 王小艳 2006中国处方药2006,5,10:1
10A Lipophilic Thioflavin-T Derivative for Positron Emission Tomography (PET) Imaging of Amyloid in Brain显示文摘Mathis C A Baeskai B J Kajdasz S T 2002Bioorg Med Chem Lett2002,12,:1
11In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by muhiphoton microscopy 显示文摘MCLELLAN M E KAJDASZ S T HYMAN B T 2003Neuroscience2003,23,:1
12Satfey and tolerability of Reboxetine in thetreatment of major depressive disorder :analysis of pooled data from eight placebo-controlled clinical trials显示文摘Hudson JI Wohlreich MM Kajdasz DK 2005Hum psychopaharmacol2005,66,6:1
13A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder 显示文摘KHAN A CUTLER AJ KAJDASZ DK et d 2011J Clin Psychiatry2011,72,4:1
14A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amy- loid in brain显示文摘Mathis CA Bacskai BJ Kajdasz ST 2002Bioorg Med Chem Lett2002,12,3:1
15A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder 显示文摘ROBINSON D KAJDASZ DK GALLIPOLI S 2011J Clin Psychophar- macol2011,31,5:1
16A Lipohilic Thioflavin-T Derivative for Positron Emission Tomography (PET) Imaging of Amyloid in Brain显示文摘Chester A Matis Brian J Bacski Stephen T Kajdasz 2002Bioorg Med Chem Lett2002,12,:1
17Invivo imaging of reactive oxygen species specificallyassociated with thioflavine S -positive amyloid plaquesby multiphoton microscopy显示文摘MCLELLAN M E KAJDASZ S T HYMAN B T 2003J Neurosci2003,23,6:1
18A randomized, dou- ble - blind Comparison of duloxetine and venlafaxine in the treat- ment of patients with major depression disorder显示文摘Perahia D G Pritchett Y L Kajdasz D K 2008J Psychiatr Res2008,42,1:1
19A Lipophilic Thioflavin-T Derivative for Positron Emission Tomography (PET) Imaging of Amyloid in Brain显示文摘Mathis CA Bacskai BJ Kajdasz ST 2002Bioorg Med Chem Lett2002,12,:1
20Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials显示文摘HUDSON JI WOHLREICH MM KAJDASZ DK 2005Hum Psychopharmacol2005,20,5:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费